Need Support?
Hematology and coagulation billing isn’t chemistry billing with different CPT codes. Differential methodology, reflex smear protocols, factor assay documentation, and anticoagulation monitoring create coding traps; 85025 for 85027, or 85610 without ICD-10, that generalists never recognize as a pattern. The loss isn’t one event; it’s a slow bleed across thousands of low-dollar claims nobody’s watching.
Automated Versus Manual Differential Confusion
CBC Frequency Limit Violations
Missed Reflex-to-Manual-Differential Revenue
Coagulation Panel Component Miscoding
Home INR and Anticoagulation Monitoring Coding Errors
Complete blood count with automated differential (85025), CBC without differential (85027), manual differential (85007), each component alone — hematocrit (85014), hemoglobin (85018), WBC count (85048), platelet count (85049) — and reticulocyte count (85045).
85025, 85027, and the individual component codes cannot be billed together on the same date under NCCI; the deciding factor is whether the order specifically requested a differential, and that distinction alone drives most CBC-related denials.
Prothrombin time PT/INR (85610), partial thromboplastin time PTT (85730), thrombin time (85670), fibrinogen (85384), D-dimer (85379), factor assays (85240–85293), von Willebrand studies, and lupus anticoagulant evaluation (85613).
Factor assay claims require documentation linking the specific factor tested to a clinical indication such as unexplained bleeding, pre-surgical workup, or known factor deficiency; missing that linkage is one of the most frequent medical-necessity denial triggers in coagulation billing.
Peripheral blood smear interpretation (85060), bone marrow aspiration (38220), bone marrow biopsy (38221), combined aspiration and biopsy (38222), iron stain (85536), and cytochemical staining for leukemia workup.
Bone marrow procedure codes and their associated pathology interpretation must be billed with the correct technical/professional split, and bundling edits apply when aspiration and biopsy are performed at the same session without the combined code.
Platelet aggregation studies (85576), platelet function assay / PFA (85576, 85597), heparin-induced thrombocytopenia antibody testing (85306), and ristocetin cofactor assays for von Willebrand disease.
Platelet function testing carries payer-specific prior authorization requirements in many commercial plans, and claims submitted without a documented bleeding history or pre-procedure indication are routinely denied for lack of medical necessity.
BCR-ABL1 quantitative PCR (81206–81208), JAK2 mutation analysis (81279), flow cytometry for leukemia and lymphoma immunophenotyping (88184–88189), and PNH clone testing by flow cytometry.
Molecular hematology and flow cytometry codes are billed per antibody or per marker studied, not as a flat panel fee, and payer medical policies frequently require a confirmed or suspected malignancy diagnosis before authorizing reimbursement.
Home INR monitor demonstration and training (G0248), provision of home INR test materials billed per four tests (G0249), and physician review and interpretation of home INR results billed per four tests (G0250).
Coverage is limited to patients with a mechanical heart valve, chronic atrial fibrillation, or venous thromboembolism, and G0249 cannot be billed more often than weekly — exceeding that frequency or billing G0250 without documented physician review is a recurring denial pattern in Coumadin clinic billing.
TransLabs’ specialized RCM services are built exclusively for labs, addressing the unique challenges that generalist billers miss. We provide end-to-end revenue cycle solutions designed specifically to turn laboratory complexity into profitability.
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.
Each Medicare Administrative Contractor maintains its own LCD specifying which ICD-10 codes support coverage for CBCs, coagulation studies, and molecular hematology markers. TransLabs maintains live LCD databases for every MAC and validates diagnosis code linkage on every hematology and coagulation claim before submission.
CPT 85025 is generally limited to once every 90 days for chronic condition monitoring, and home INR testing under G0249 cannot be billed more often than weekly. TransLabs tracks each patient's claim history against these limits and alerts ordering providers before a frequency cap is reached.
Automated and manual differential codes, individual CBC components, and certain coagulation panel components are subject to National Correct Coding Initiative edits that prevent same-date billing. TransLabs runs every hematology and coagulation claim through an NCCI edit check before it leaves our system, not after a denial arrives.
When a beneficiary requests a coagulation or molecular hematology test that may not meet medical necessity criteria under the applicable LCD, a valid ABN must be issued before the test is performed. TransLabs builds ABN workflows into front-end registration so the documentation is always in place.
The CLFS sets Medicare payment rates for CBC, coagulation, and hematology panel codes and updates annually on January 1. TransLabs monitors CLFS changes, updates billing tables immediately, and flags payers reimbursing below CLFS rates.
Labs meeting the applicable laboratory definition under PAMA carry mandatory private payer data reporting obligations, and hematology and coagulation test volumes are frequently part of that reporting base. TransLabs tracks these obligations and ensures reporting deadlines are met.
Genetic and molecular hematology testing — including BCR-ABL and JAK2 panels — has drawn increased OIG scrutiny in recent audit cycles. TransLabs builds compliance protocols specifically around current OIG focus areas to reduce your audit exposure before it becomes a problem.
Hematology and coagulation billing has its own methodology, NCCI bundling rules, anticoagulation codes, and frequency limits. TransLabs was built for lab billing; coders stay in hematology and coagulation; not chemistry one week, coagulation next.
Dedicated hematology & coagulation billing specialist assigned to your lab
Complimentary 12-month claims audit across Medicare, Medicaid, and commercial payers
Uncover your top 3 revenue leaks in differential coding, factor assays, and anticoagulation monitoring
Custom strategy tailored to your analyzer platform and LIS/billing software
Live in 24 hours with no contracts and no upfront fees
Pay only a percentage of what we collect for you
85025 is a complete blood count with an automated differential; 85027 is a CBC without a differential. The determining factor is what the ordering provider’s documentation actually requested; if the order doesn’t specify a differential, billing 85025 anyway is one of the most common hematology denial triggers.